Literature DB >> 24036400

Placental pathology suggesting that preeclampsia is more than one disease.

David B Nelson1, Mandolin S Ziadie2, Donald D McIntire3, Beverly B Rogers2, Kenneth J Leveno3.   

Abstract

OBJECTIVE: Our purpose was to evaluate the placental pathology in women with preeclampsia occurring at varying gestational ages. STUDY
DESIGN: This was a secondary analysis of a prospective observational study of placentas from prespecified complicated pregnancies routinely submitted for standardized examination. For this study, a database of placental diagnoses from liveborn singleton gestations without major malformations was linked to a computerized obstetric database. The rates of standardized placental findings including vascular (atherosis, infarction) and nonvascular (hyperplasia) changes were evaluated according to gestational age at diagnosis of preeclampsia.
RESULTS: Between Jan. 1, 2001, and Sept. 30, 2007, a total of 7122 women with pregnancies complicated by preeclampsia were delivered at our hospital. Of these, 1210 (17%) had placental examinations. Within this cohort, 209, 355, and 646 women were diagnosed with preeclampsia at gestations of 24(0/67) to 33(6/7), 34(0/7) to 36(6/7), and 37(0/7) weeks or longer, respectively. Placental findings revealed hypoplasia was significantly associated with preeclampsia early in the third trimester, and histological evidence of placental vascular lesions was significantly increased at gestations of 24(0/67) to 33(6/7) weeks (53%) compared with 34% and 26% at 34(0/7) to 36(6/7) and 37 weeks or longer, respectively (P < .001).
CONCLUSION: The placentas of women with preeclampsia onset before 34 weeks' gestation were significantly different from those with preeclampsia at term. The former group demonstrated placental findings predominantly consistent with insufficiency because of vascular abnormalities. Such differing placental findings support the hypothesis that preeclampsia is a different disease, depending on the gestational age at diagnosis.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  placental pathology; preeclampsia

Mesh:

Year:  2013        PMID: 24036400     DOI: 10.1016/j.ajog.2013.09.010

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  38 in total

1.  Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.

Authors:  Karoline Mayer-Pickel; Katharina Eberhard; Uwe Lang; Mila Cervar-Zivkovic
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 2.  The human placental methylome.

Authors:  Wendy P Robinson; E Magda Price
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

3.  Risk of Preeclampsia in Pregnancies After Assisted Reproductive Technology and Ovarian Stimulation.

Authors:  Angela S Martin; Michael Monsour; Jennifer F Kawwass; Sheree L Boulet; Dmitry M Kissin; Denise J Jamieson
Journal:  Matern Child Health J       Date:  2016-10

4.  Stillbirth, hypertensive disorders of pregnancy, and placental pathology.

Authors:  Karen J Gibbins; Robert M Silver; Halit Pinar; Uma M Reddy; Corette B Parker; Vanessa Thorsten; Marian Willinger; Donald J Dudley; Radek Bukowski; George R Saade; Matthew A Koch; Deborah Conway; Carol J Hogue; Barbara J Stoll; Robert L Goldenberg
Journal:  Placenta       Date:  2016-05-07       Impact factor: 3.481

5.  Decidual granulomatous reaction in a placenta from a preeclamptic pregnancy: a case report and review of the literature.

Authors:  Simon B Chen; Satoru Kudose; Hannah R Krigman
Journal:  Virchows Arch       Date:  2018-03-14       Impact factor: 4.064

6.  Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.

Authors:  Steven J Korzeniewski; Roberto Romero; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Chong Jai Kim; Yeon Mee Kim; Jung-Sun Kim; Bo Hyun Yoon; Sonia S Hassan; Lami Yeo
Journal:  Am J Obstet Gynecol       Date:  2015-12-11       Impact factor: 8.661

7.  Effects of excess thromboxane A2 on placental development and nutrient transporters in a Mus musculus model of fetal growth restriction.

Authors:  Karen J Gibbins; Katherine N Gibson-Corley; Ashley S Brown; Matthew Wieben; Richard C Law; Camille M Fung
Journal:  Biol Reprod       Date:  2018-05-01       Impact factor: 4.285

Review 8.  Preeclampsia: Syndrome or Disease?

Authors:  Leslie Myatt; James M Roberts
Journal:  Curr Hypertens Rep       Date:  2015-11       Impact factor: 5.369

Review 9.  [Pathoanatomical and clinical aspects of the placenta in preterm birth].

Authors:  H Feist; C von Kaisenberg; K Hussein
Journal:  Pathologe       Date:  2017-07       Impact factor: 1.011

10.  FOXO1 expression in villous trophoblast of preeclampsia and fetal growth restriction placentas.

Authors:  Rachel Sheridan; Chethan Belludi; Jane Khoury; Jerzy Stanek; Stuart Handwerger
Journal:  Histol Histopathol       Date:  2014-09-09       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.